Abstract
Sequencing of the human genome has opened the door to the most exciting new era for studying complex genetic traits. Positional cloning is a powerful approach, and is aimed at the identification and cloning genes, based on their chromosomal location identified through linkage analysis. The past decade has seen substantial success in identifying genes responsible for monogenic disorders while progress in gene identification for more common, multifactorial diseases has been slower. With completion of human genome sequencing the relevance of this approach is growing, with the rapidly increasing information and characterization of the human genome providing the opportunity to resolve complex diseases, as demonstrated in several recent studies. Recently, we identified a susceptibility locus for human Uric Acid Nephrolithiasis (UAN) on 10q21-q22 and showed that a variant of a novel gene encoding a specific protein is associated with Uric Acid Nephrolithiasis (OMIM 605990). Inspired by this successful identification, this paper briefly summarizes the genetical basis of Uric Acid Nephrolithiasis, and the evolutionary adaptation of the predisposing gene in a complex puzzle of inherited factors that we have disclosed through a comparative genomic approach.
Keywords: uric acid nephrolithiasis, human genome sequencing, positional cloning, genomic approach
Current Genomics
Title: Genes, Human Diseases and Genome Evolution in the Post-Genomic Era: Insights from Uric Acid Nephrolithiasis
Volume: 6 Issue: 3
Author(s): Fernando Gianfrancesco and Teresa Esposito
Affiliation:
Keywords: uric acid nephrolithiasis, human genome sequencing, positional cloning, genomic approach
Abstract: Sequencing of the human genome has opened the door to the most exciting new era for studying complex genetic traits. Positional cloning is a powerful approach, and is aimed at the identification and cloning genes, based on their chromosomal location identified through linkage analysis. The past decade has seen substantial success in identifying genes responsible for monogenic disorders while progress in gene identification for more common, multifactorial diseases has been slower. With completion of human genome sequencing the relevance of this approach is growing, with the rapidly increasing information and characterization of the human genome providing the opportunity to resolve complex diseases, as demonstrated in several recent studies. Recently, we identified a susceptibility locus for human Uric Acid Nephrolithiasis (UAN) on 10q21-q22 and showed that a variant of a novel gene encoding a specific protein is associated with Uric Acid Nephrolithiasis (OMIM 605990). Inspired by this successful identification, this paper briefly summarizes the genetical basis of Uric Acid Nephrolithiasis, and the evolutionary adaptation of the predisposing gene in a complex puzzle of inherited factors that we have disclosed through a comparative genomic approach.
Export Options
About this article
Cite this article as:
Gianfrancesco Fernando and Esposito Teresa, Genes, Human Diseases and Genome Evolution in the Post-Genomic Era: Insights from Uric Acid Nephrolithiasis, Current Genomics 2005; 6 (3) . https://dx.doi.org/10.2174/1389202053971965
DOI https://dx.doi.org/10.2174/1389202053971965 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Quinone-Based Drugs: An Important Class of Molecules in Medicinal Chemistry
Medicinal Chemistry Obesity: The Metabolic Disease, Advances on Drug Discovery and Natural Product Research
Current Topics in Medicinal Chemistry Immune Response, Diagnosis and Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis Lung Disease
Current Pharmaceutical Design Editorial (Thematic Issue: Nanoinformatics to Organic Synthesis, ADMET Profiling, and Application of Nanomaterials in Medicinal Chemistry, Medicine, and Biotechnology)
Current Topics in Medicinal Chemistry Bronchiolitis Care in the Hospital
Reviews on Recent Clinical Trials The Role of Cnidaria in Drug Discovery. A Review on CNS Implications and New Perspectives
Recent Patents on CNS Drug Discovery (Discontinued) Anti-Tumor Necrosis Factor-Alpha (TNF-α) Treatment Strategies in Crohns Disease
Recent Patents on Inflammation & Allergy Drug Discovery Novel Anti-inflammatory Drugs from Marine Microbes
The Natural Products Journal Monocyclic and Fused Azines and Azoles as Histamine H<sub>4</sub> Receptor Ligands
Current Medicinal Chemistry CD28: A New Drug Target for Immune Disease
Current Drug Targets The Role of MIF in Hepatic Function, Oxidative Stress, and Inflammation in Thioacetamide-induced Liver Injury in Mice: Protective Effects of Betaine
Current Medicinal Chemistry The Promise of Plant-Derived Substances as Inhibitors of Arginase
Mini-Reviews in Medicinal Chemistry Omega – 3 Fatty Acids as Pharmacotherapeutics in Psoriasis: Current Status and Scope of Nanomedicine in its Effective Delivery
Current Drug Targets Lung Dendritic Cells: Targets for Therapy in Allergic Disease
Current Molecular Medicine Medicinal Plant <i>Centipeda Minima</i>: A Resource of Bioactive Compounds
Mini-Reviews in Medicinal Chemistry Clostridial Neurotoxins: Mode of Substrate Recognition and Novel Therapy Development
Current Protein & Peptide Science Leptin: The Prototypic Adipocytokine and its Role in NAFLD
Current Pharmaceutical Design Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Exome Sequencing of Ovarian Cancer Patients to Identify Variants Predictive of Sensitivity to Platinum-based Chemotherapy
Current Pharmacogenomics and Personalized Medicine Novel Pharmacologic Approaches to the Management of Sepsis: Targeting the Host Inflammatory Response
Recent Patents on Inflammation & Allergy Drug Discovery